Back
Supernus Pharmaceuticals Stock Predictions
Sponsored
SUPN
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
38
SUPN
Supernus Pharmaceuticals
Last Price:
30.09
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.Supernus Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 25.9% based on the past 11 years of stock performance.
- Supernus Pharmaceuticals has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Supernus Pharmaceuticals Stock Undervalued?
The current Supernus Pharmaceuticals [SUPN] share price is $30.06. The Score for SUPN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 25.9% based on the past 11 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Sell
38
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals overpriced?
- Supernus Pharmaceuticals has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
38.09
52-Week Low:
21.99
Prediction Charts
Market Cap:
1.65B
Price in USD:
30.06
Volume:
348.1K
Beta:
1.13
Technical Analysis
SMA50:
31.52
SMA100:
29.76
SMA200:
29.08
52-Wk Change:
-18.65%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?
Yes, Supernus Pharmaceuticals is a publicly traded company. -
What is the Supernus Pharmaceuticals stock quote today?
The Supernus Pharmaceuticals stock price is 30.06 USD today. -
How to buy Supernus Pharmaceuticals stock online?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-12 | 31.98 | 30.24 | 31.98 | 30.08 |
Apr-15 | 30.51 | 29.99 | 30.60 | 29.68 |
Apr-16 | 30.00 | 29.43 | 30.40 | 29.35 |
Apr-17 | 29.74 | 28.99 | 30.08 | 28.88 |
Apr-18 | 28.87 | 28.88 | 29.48 | 28.63 |
Apr-19 | 28.67 | 29.42 | 29.53 | 28.67 |
Apr-22 | 29.56 | 29.71 | 30.30 | 29.28 |
Apr-23 | 29.75 | 29.98 | 31.84 | 29.59 |
Apr-24 | 29.96 | 30.26 | 30.40 | 29.82 |
Apr-25 | 30.03 | 29.31 | 30.22 | 29.17 |
Apr-26 | 29.46 | 30.07 | 30.19 | 29.17 |
Apr-29 | 30.35 | 30.60 | 31.27 | 30.35 |
Apr-30 | 30.40 | 30.09 | 30.70 | 30.03 |
May-1 | 30.15 | 30.06 | 30.69 | 29.99 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.35 per share, and an increase next year of $0.31 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.